Daiichi Sankyo Reps Continue Heavy Pitches for Tarlige in September: Impact Track

December 6, 2019
Sales reps at Daiichi Sankyo continued their heavy promotion for the pain treatment Tarlige (mirogabalin) in September following its Japan launch in mid-April, an industry survey showed. The “Impact Track” detailing track survey, conducted by market research firm Intage Healthcare,...read more